Clin Exp Pediatr.
2021 Dec;64(12):619-627. 10.3345/cep.2021.00213.
Endocrine comorbidities of pediatric obesity
- Affiliations
-
- 1Department of Pediatrics, Inje University Ilsan Paik Hospital, Goyang, Korea
- 2Department of Pediatrics, Seoul National University Bundang Hospital, Seongnam, Korea
- 3Department of Pediatrics, Seoul National University College of Medicine, Seoul, Korea
- KMID: 2522661
- DOI: http://doi.org/10.3345/cep.2021.00213
Abstract
- Pediatric obesity has become a serious public health issue. The prevalence of obesity in children and adolescents has increased worldwide and in Korea over several decades. Obese children are more likely to be obese adults with an increased cardiovascular risk. Therefore, maintaining a healthy weight and preventing obesity during childhood are of critical importance. Moreover, obese children and adolescents often have endocrine comorbidities such as prediabetes, type 2 diabetes, dyslipidemia, metabolic syndrome, polycystic ovary syndrome, and central precocious puberty. Hence, the early implementation of obesity management using a multidisciplinary team approach and screening for these comorbidities in obese children and adolescents are required with the appropriate management of each comorbidity and/or specialist referral.
